AMERICAN CLINICAL LABORATORY ASSN for AMERICAN CLINICAL LABORATORY ASSN
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Disaster Planning/Emergencies DIS
Reauthorization of the Pandemics and All-Hazards Preparedness Act (PL. 109-417)
| Lobbyist | Covered position, as disclosed |
|---|---|
| HOLLY GROSHOLZ New | — |
| THOMAS B SPARKMAN | — |
| SUSAN VAN METER | — |
Medical/Disease Research/Clinical Labs MED
Reimbursement and coverage issues for and related to clinical laboratory services, including the Medicare clinical laboratory fee schedule, new test coding and pricing, definitive drug testing coding, coverage, and payment, and implementation of the Protecting Access to Medicare Act (P.L. 113-93); FDA and CMS policies related to diagnostics and laboratory regulation; reauthorization of the Pandemics and All-Hazards Preparedness Act (PL. 109-417); access to clinical laboratory services pursuant to a telehealth visit, issues related to health care and laboratory workforce shortages; data privacy and protection changes potentially impacting HIPAA-covered entities. Saving Access to Laboratory Services Act H.R. 2377/S. 1000, VALID Act H.R. 2369.
| Lobbyist | Covered position, as disclosed |
|---|---|
| HOLLY GROSHOLZ | — |
| THOMAS B SPARKMAN | — |
| SUSAN VAN METER | — |
Medicare/Medicaid MMM
Reimbursement and coverage issues for and related to clinical laboratory services, including the Medicare clinical laboratory fee schedule, new test coding and pricing, definitive drug testing coding, coverage, and payment, and implementation of the Protecting Access to Medicare Act (P.L. 113-93); access to clinical laboratory services pursuant to a telehealth visit Saving Access to Laboratory Services Act H.R. 2377/S. 1000,
| Lobbyist | Covered position, as disclosed |
|---|---|
| HOLLY GROSHOLZ | — |
| THOMAS B SPARKMAN | — |
| SUSAN VAN METER | — |
Budget/Appropriations BUD
Policies related to diagnostics and laboratory regulation
| Lobbyist | Covered position, as disclosed |
|---|---|
| HOLLY GROSHOLZ | — |
| THOMAS B SPARKMAN | — |
| SUSAN VAN METER | — |
Health Issues HCR
Reimbursement and coverage issues for and related to clinical laboratory services, including the Medicare clinical laboratory fee schedule, new test coding and pricing, definitive drug testing coding, coverage, and payment, and implementation of the Protecting Access to Medicare Act (P.L. 113-93); FDA and CMS policies related to diagnostics and laboratory regulation; reauthorization of the Pandemics and All-Hazards Preparedness Act (PL. 109-417); access to clinical laboratory services pursuant to a telehealth visit, issues related to health care and laboratory workforce shortages; data privacy and protection changes potentially impacting HIPAA-covered entities. Saving Access to Laboratory Services Act H.R. 2377/S. 1000, VALID Act H.R. 2369.
| Lobbyist | Covered position, as disclosed |
|---|---|
| HOLLY GROSHOLZ | — |
| THOMAS B SPARKMAN | — |
| SUSAN VAN METER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.